Global serological transplant diagnostics market forecast
According to the serological transplant diagnostics industry analysis, the global serological transplant diagnostics market will grow at a CAGR of more than 4% during the forecast period. Mergers and acquisitions between small specialized hospitals and Tier-1 hospitals will drive the growth prospects for the market and will increase the serological transplant diagnostics market value during the predicted period. The acquisition of small hospitals by large Tier-1 hospitals results in an improved organ transplantation, care, and diagnosis. This will drive the demand for transplant diagnostic products, assays, and kits as more people opt for large hospitals to access healthcare services. Such acquisitions promote training for healthcare staff including physicians and nurses. A range of patient monitoring equipment is introduced in large hospitals that will drive the influx of the patient pool. The adoption of mergers and acquisition strategies also improves the brand value of these hospitals by introducing specialty services such as serological transplant diagnostics.
In the Americas, the US was the largest revenue contributor to the serological transplant diagnostics market during 2016. The region is witnessing a high incidence of organ failure due to unhealthy diets, consumption of alcohol, and severe diseases such as end-stage kidney renal disease (ESRD) and liver cirrhosis. This drives the demand for transplantation products such as tissues, immunosuppressant drugs, and alternative technologies. The Americas will continue to account for the largest shares of the human leukocyte antigen (HLA) typing market and this will attribute to the introduction of advanced surgical instruments.
Competitive landscape and key vendors
The serological transplant market is characterized by the presence of established players. These vendors are increasingly competing against each other based on factors such as aggressive pricing, product differentiation, capital support for product or technology upgradation, and distribution partnerships. Manufacturers of transplantation products are increasingly focusing on the development of molecular diagnostic products. To increase their brand popularity in the human leukocyte antigen (HLA) typing market, they are also investing in the development of high-grade gene sequencers with NGS technology and serological assays and kits.
Key vendors in this market are
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Other prominent vendors in the market include Agena Bioscience, AVIOQ, BAG Healthcare, BD, Beckman Coulter, Biocell Medicare, Biogenuix, DIAGAST,Grifols, Hemo bioscience, Institut de Biotechnologies, Lorne Laboratories, MTC INVITRO, Quotient Biodiagnostics, Reagent Kft, and Tulip.
Segmentation by application and analysis of the serological transplant diagnostics market
Chronic kidney disease increases the risk of cardiovascular disease (CVD) and end-stage kidney renal disease (ESRD). The recent years witnessed a rise in the number of kidney transplantation procedures. The reduction in the average cost of gene sequencing will positively influence the growth of the human leukocyte antigen (HLA) typing market in the kidney transplantation segment. Additionally, the emergence of advanced serological diagnostic technologies will also boost the adoption of kidney transplantation procedures and will aid in serological transplant diagnostics market growth.
Segmentation by end-user and analysis of the serological transplant diagnostics market
Hospitals, blood banks, and transplant centers
Donor registries and research laboratories
The hospitals, blood banks, and transplant centers were the major end-users to the serological transplant diagnostics market during 2016. Hospitals maintain high-quality transplantation products to increase the treatment efficiency and reduce the number of graft rejections. Countries such as the US, the UK, and China are experiencing an increased need for blood banks due to the rising demand for transplantation and healthcare coverage. Most of these blood banks are integrated with hospitals. Organ transplant hospitals are also linked with organ procurement and transplant centers that provide improved care to people who require organ transplantation.